Labiana Health, S.A. (BME:LAB)

Spain flag Spain · Delayed Price · Currency is EUR
4.660
0.00 (0.00%)
At close: Dec 24, 2025
124.04%
Market Cap32.60M
Revenue (ttm)71.67M
Net Income (ttm)904.36K
Shares Out7.00M
EPS (ttm)0.13
PE Ratio36.04
Forward PE12.93
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume906
Openn/a
Previous Close4.660
Day's Rangen/a
52-Week Range2.100 - 4.900
Beta0.22
RSI53.91
Earnings DateApr 22, 2026

About Labiana Health

Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized dosage forms, bacterial vaccines and biological formats; and Fosfomycin trometamol under the Fosfomicina Labiana brand name. In addition, the company offers contrac... [Read more]

Sector Healthcare
Founded 1958
Employees 369
Stock Exchange Madrid Stock Exchange
Ticker Symbol LAB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.